|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Global Analytics Receives $25,000,000 Series D Financing Round
|
VentureDeal |
05/24/12 |
San Diego
|
|
Sue Siegel Leaves MDV to Run $6B GE Health Unit
|
Luke Timmerman |
05/21/12 |
San Francisco
|
|
Coupa Software Garners $22,000,000 Series E Funding Round
|
VentureDeal |
05/10/12 |
San Francisco
|
|
The Affymetrix Alumni: Where Are They Now?
|
Luke Timmerman |
05/02/12 |
San Francisco
|
|
ParAccel Receives $20,000,000 New Funding Round
|
VentureDeal |
04/26/12 |
San Diego
|
|
Crescendo Bioscience Takes Arthritis Into the World of Hard Data
|
Luke Timmerman |
02/24/12 |
San Francisco
|
|
GreatPoint, Enanta, NextView, & More Boston Dealmakers
|
Erin Kutz |
02/22/12 |
Boston
|
|
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News
|
Erin Kutz |
02/17/12 |
Boston
|
|
On-Q-ity Raises $5M, Names GSK Vet as CEO
|
Arlene Weintraub |
02/15/12 |
Boston
|
|
On-Q-ity Secures $5,000,000 Series B Funding Round
|
VentureDeal |
02/15/12 |
Boston
|
|
VirtuOz Says Virtual Agents are “Siri for the Enterprise”
|
Wade Roush |
01/12/12 |
San Francisco
|
|
PacBio CEO Hugh Martin Resigns, Being Replaced by Mike Hunkapiller
|
Luke Timmerman |
01/06/12 |
San Francisco
|
|
While Politicians Fight, Entrepreneurs Focus on “Smart Health”
|
Rowan Chapman |
12/06/11 |
San Francisco
|
|
HealthTap Obtains $11,500,000 Series A Funding Round
|
VentureDeal |
12/06/11 |
San Francisco
|
|
CardioDx Passes Trial, Determining When Chest Pain Is No Big Deal
|
Luke Timmerman |
11/15/11 |
San Francisco
|
|
PunchTab Receives $4,400,000 Series A Round
|
VentureDeal |
11/08/11 |
San Francisco
|
|
Massive Health Builds an App for Healthy Eating; Think Foodspotting Meets FitnessKeeper
|
Wade Roush |
11/02/11 |
San Francisco
|
|
The Web’s Last Word on Words
|
Wade Roush |
10/26/11 |
San Francisco
|
|
How Will the $1,000 Genome Change Society? Hear From Wired’s Thomas Goetz, MDV’s Sue Siegel, Kauffman’s John Wilbanks on Monday
|
Luke Timmerman |
10/21/11 |
San Francisco
|
|
Computing in the Age of the $1,000 Genome: Here’s the Program for Monday’s Conference
|
Luke Timmerman |
10/19/11 |
San Francisco
|
|
TechStars Pins Down $24M, Visible Measures Gets $13M Series D, Yesware Announces Seed Funding, & More Boston-Area Deals News
|
Erin Kutz |
09/28/11 |
Boston
|
|
Complete Genomics, PacBio CEOs to Lead Off “Computing in the Age of the $1K Genome” Oct. 24
|
Luke Timmerman |
09/27/11 |
San Francisco
|
|
Visible Measures Sees $13M Series D, Goes After Social Video Advertising
|
Gregory T. Huang |
09/22/11 |
Boston
|
|
Visible Measures Secures $13,000,000 Series D Financing
|
VentureDeal |
09/22/11 |
Boston
|
|
Computing in the Age of the $1,000 Genome. Our Next Big Event in SF Oct. 24
|
Luke Timmerman |
09/14/11 |
San Francisco
|
|
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy
|
Luke Timmerman |
09/08/11 |
San Francisco
|
|
Crescendo Bioscience Secures $31,000,000 Series C Round
|
VentureDeal |
09/08/11 |
San Francisco
|
|
RootMusic Garners $16,000,000 Series B Financing Round
|
VentureDeal |
08/31/11 |
San Francisco
|
|
Computing in the Age of the $1,000 Genome: Speakers from Wired, Fortune Join All-Star Lineup
|
Luke Timmerman |
08/30/11 |
San Francisco
|
|
San Diego’s Genomatica, a Pioneer in Industrial Biotechnology, Files for IPO
|
Bruce V. Bigelow |
08/24/11 |
San Diego
|
|
Page 1 of
6 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.